🇺🇸 FDA

Company profile · Sponsor

Galera

Galera Therapeutics

GRTX · NYSE pharma MALVERN, PA, USA
Pipeline
17
Drugs
0
Patents
8

Quick answer

Galera (GRTX) is a pharma company. headquartered in MALVERN, PA, USA. listed on NYSE. NovaPharmaNews links 17 pipeline programs, 0 drugs, and 8 patents to this profile..

Company facts

Ticker GRTX
Exchange NYSE
Company type pharma
Headquarters MALVERN, PA, USA
SEC CIK 0001563577

Pipeline (17)

Search pipeline →

  1. GC4419 90mg

    Galera

    Oral Mucositis

    phase 3 small molecule completed

    1 trial

  2. Drug GC4711

    Galera

    SBRT

    phase 2 small molecule terminated

    1 trial

  3. Drug: GC4419

    Galera

    Head and Neck Cancer

    phase 2 small molecule completed

    1 trial

  4. GC4419

    Galera

    Pancreatic Cancer

    phase 2 small molecule completed

    1 trial

  5. GC4419

    Galera

    Covid19

    phase 2 small molecule terminated

    1 trial

  6. GC4419 (avasopasem manganese)

    Galera

    Esophagitis

    phase 2 small molecule terminated

    1 trial

  7. GC4711 +SBRT

    Galera

    SBRT

    phase 2 small molecule terminated

    1 trial

  8. Low Dose GC4419: 30mg/day

    Galera

    Radiation Induced Oral Mucositis

    phase 2 small molecule completed

    1 trial

  9. Dextromethorphan HBr

    Galera

    Healthy

    phase 1 small molecule completed

    1 trial

  10. GC4419

    Galera

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  11. GC4419

    Galera

    Renal Impairment

    phase 1 small molecule completed

    1 trial

  12. GC4419

    Galera

    Squamous Cell Carcinoma of the Oral Cavity

    phase 1 small molecule completed

    1 trial

  13. GC4419 IV

    Galera

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  14. GC4702 dry powder

    Galera

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  15. GC4711 30 mg IV

    Galera

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  16. GC4711 30mg

    Galera

    Healthy

    phase 1 small molecule completed

    1 trial

  17. GC4711 Oral Capsule G-101

    Galera

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

Patents (8)

Search patents →

  1. US 12220420

    Combination therapy for cancer treatment

    Expires Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12156863

    Combination cancer therapy with pentaaza macrocyclic ring complex and ascorbate compound

    Expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12077549

    Pentaaza macrocyclic ring complexes possessing oral bioavailability

    Expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11826373

    Methods for treatment of diseases

    Expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11612608

    Methods of treating oral mucositis

    Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11246950

    Combination cancer immunotherapy with pentaaza macrocyclic ring complex

    Expires Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11219614

    Combination cancer therapy with pentaaza macrocyclic ring complex and ascorbate compound

    Expires Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11066433

    Pentaaza macrocyclic ring complexes possessing oral bioavailability

    Expires Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Galera?

Galera (GRTX) is a pharma company. headquartered in MALVERN, PA, USA. listed on NYSE. NovaPharmaNews links 17 pipeline programs, 0 drugs, and 8 patents to this profile..

What pipeline programs does Galera sponsor?

We track 17 ClinicalTrials.gov-linked programs for Galera, including GC4419 90mg and 16 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Galera company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.